Bio Path | BPTH - Passivo Circulante





Passivo Circulante Alterar Data
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Baxter International USD 3.69B 723M 2026-03
Bio Path USD 9.15M 468K 2026-03
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.57M 2.29M 2025-12
CSL USD 4.61B 207M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12